Other committees

In addition to the Board Committees, certain other committees have been established to perform specific functions.

Find out what the role of each committee is, who sits on them, and how often they meet.

Corporate Executive Team

Membership

Chairman:

  • Emma Walmsley

Members:

  • Roger Connor - President, Global Manufacturing and Supply
  • Luc Debruyne - President, Global Vaccines
  • Simon Dingemans - Chief Financial Officer
  • Nick Hirons - Senior Vice President, Global Ethics and Compliance
  • Brian McNamara - CEO, GSK Consumer Healthcare
  • Luke Miels - President, Global Pharmaceuticals 
  • David Redfern - Chief Strategy Officer & Chairman, ViiV Healthcare
  • Karenann Terrell - Chief Digital & Technology Officer
  • Claire Thomas - Senior Vice President, Human Resources
  • Phil Thomson - President, Global Affairs
  • Dan Troy - Senior Vice President & General Counsel
  • Dr Hal Barron - Chief Scientific Officer and President, R&D

Secretary:

  • SVP, Office of CEO

Frequency of meetings: 

  • The CET meets 11 times per year.

The CET assists the CEO in the executive management of the company.

Back to top

Risk Oversight and Compliance Council (ROCC)

Membership

The Risk Oversight and Compliance Council (ROCC) is Co-chaired by the Corporate Compliance Officer (Senior Vice President, Global Ethics and Compliance), and the Chief Financial Officer, and includes at least three members of the Corporate Executive Team appointed by the CEO. Other members include the General Counsel, Company Secretary and the Head of Audit & Assurance.
Additional members may be added by the ROCC Chairman from time to time as appropriate.

Purpose

The ROCC assists the Audit & Risk Committee in its review of activities and helps to ensure that effective internal controls are implemented for all significant risks. The establishment of the ROCC was approved by our Board, guided by the Corporate Compliance Officer. 

Reporting line

In accordance with its role, the Audit & Risk Committee reviews information and reports from the ROCC and in turn reports to our Board on these matters.

Responsibility

The ROCC is responsible for carrying out the following tasks:

  • Ensure a robust process exists for the business to identify significant risks to which GSK is exposed
  • Ensure Enterprise Risk Strategies are fit for purpose, root causes of significant incidents and adverse audit outcomes are understood, and effective corrective and preventive actions are implemented
  • Escalate issues, critical audit findings or risks to the Corporate Executive Team and Audit & Risk Committee that require action or where significant exposure to GSK may exist
  • Ensure effective communication and reporting of important risk and control information between other key risk committees, Corporate Executive Team and Audit & Risk Committee
  • Deliver visible leadership in promoting GSK’s values as part of risk management
Back to top

Disclosure Committee

Membership

Chairman

  • Company Secretary

Members:

  • Group Financial Controller
  • President, Global Affairs
  • Head of Investor Relations
  • Head of Investor Relations US
  • Head of Global External and Market Communications 
  • Associate General Counsel, Legal Operations-Business Development Transactions
  • Head of Legal Operations (UK & US) Regional and Dermatology

Secretary:

  • Assistant Company Secretary

In attendance:

Representatives from:
Our external auditors
Our external legal advisers UK and US
Our brokers
Internal experts (including Head of Global Finance Reporting & Analysis)

The Disclosure Committee was established by the CEO and the CFO and has responsibility for considering the materiality of information (information that may affect our stock price), and determining on a timely basis the disclosure of this information. The committee meets as necessary.

Download the Disclosure Committee's terms of reference (PDF)

Back to top